Find a Clinical Trial
Filter
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
Relapsed or refractory myeloma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
M23-362
Diffuse large B-cell lymphoma, Follicular lymphoma, Lymphomas (adult)
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
HGB-210
Sickle cell anemia
All genders
2-50
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
Gemini 1
Multiple sclerosis
All genders
18-55
Recruiting now
Department of Neurology
Hercules
Multiple sclerosis
All genders
18-60
Recruiting now
Department of Neurology
PERSEUS
Multiple sclerosis
All genders
18-55
Recruiting now
Department of Neurology
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy
Non-small cell lung cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Division of Thoracic Surgery
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
Diffuse large B-cell lymphoma
All genders
75+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
To Evaluate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
Small cell lung cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center